Quest Diagnostics Incorporated DGX
NYSE
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 1.77% | 5.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.77% | 5.11% | |||
| Cost of Revenue | 1.99% | 3.28% | |||
| Gross Profit | 1.36% | 8.90% | |||
| SG&A Expenses | -0.76% | 5.62% | |||
| Depreciation & Amortization | -2.63% | 2.70% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.32% | 3.82% | |||
| Operating Income | 4.31% | 12.90% | |||
| Income Before Tax | 0.71% | 24.85% | |||
| Income Tax Expenses | 12.50% | 18.92% | |||
| Earnings from Continuing Operations | -2.40% | 26.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | -16.67% | |||
| Net Income | -2.50% | 26.98% | |||
| EBIT | 4.31% | 12.90% | |||
| EBITDA | 3.44% | 9.32% | |||
| EPS Basic | -1.94% | 25.95% | |||
| Normalized Basic EPS | 2.16% | 21.21% | |||
| EPS Diluted | -2.11% | 26.79% | |||
| Normalized Diluted EPS | 1.24% | 22.31% | |||
| Average Basic Shares Outstanding | -0.90% | 0.91% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.02% | -0.14% | |||